Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis
Status:
Completed
Trial end date:
2018-06-20
Target enrollment:
Participant gender:
Summary
The aim of this study was to evaluate the efficacy and safety of the prophylactic effect of
intracameral moxifloxacin for prevention of postcataract endophthalmitis.
Phase:
Phase 2
Details
Lead Sponsor:
Universidade Federal de Pernambuco
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination